Generic Pharmaceuticals Businesses for Sale and Investment

• Owned a pharmaceutical formulation manufacturing unit specializing in antibiotics and beta-lactam products. • Manufactures tablets, capsules, and dry syrups under regulated pharmaceutical standards. • Product portfolio includes approximately 40 SKUs across therapeutic categories. • Produces formulations under its own brand through an established distributor network. • Also undertakes third-party/job work manufacturing for external pharma companies. • Installed tablet manufacturing capacity of around 1.5 crore tablets per month per shift. • Capsule manufacturing capacity of approximately 50 lakh capsules per month per shift. • Dry syrup production capacity of about 40,000–50,000 bottles per month per shift. • Currently operating at around 5% capacity utilization, leaving substantial headroom for scale-up. • Business activity has reduced over the past two years due to promoter health and age-related constraints. • Sales decline attributed to operational slowdown rather than market or regulatory issues. • Holds valid drug manufacturing license for regulated formulations. • Registered under GST and MSME, ensuring statutory and compliance readiness. Does not have USFDA approval. • Suitable for revival through professional management, marketing tie-ups, or strategic investment.

Generic pharmaceuticals manufacturing facility located in Rewari is available for long-term lease. - The factory comprises a built area of 1,500 sqm over two floors (G+1) and includes additional mezzanine and terrace areas. - Equipped with a non-beta lactum section for manufacturing tablets and capsules, ensuring compliance with industry standards. - The facility includes approximately 20-25 manufacturing machines valued at INR 5 crore, providing a comprehensive production setup. - The total land size is 1,000 sqm, with the land and building appraised at INR 10 crore, making it a significant asset for investors. - The factory meets the revised Schedule M standards essential for pharmaceutical manufacturing, guaranteeing adherence to regulatory requirements. - The facility is aimed at pharmaceutical companies looking to outsource production or expand their manufacturing capabilities in the generic medication sector. - The business generates income through long-term leases of the factory space, providing a lucrative opportunity for investors in the growing generic pharmaceuticals market.

Generic pharmaceuticals manufacturing facility located in Rewari is available for long-term lease. - The factory comprises a built area of 1,500 sqm over two floors (G+1) and includes additional mezzanine and terrace areas. - Equipped with a non-beta lactum section for manufacturing tablets and capsules, ensuring compliance with industry standards. - The facility includes approximately 20-25 manufacturing machines valued at INR 5 crore, providing a comprehensive production setup. - The total land size is 1,000 sqm, with the land and building appraised at INR 10 crore, making it a significant asset for investors. - The factory meets the revised Schedule M standards essential for pharmaceutical manufacturing, guaranteeing adherence to regulatory requirements. - The facility is aimed at pharmaceutical companies looking to outsource production or expand their manufacturing capabilities in the generic medication sector. - The business generates income through long-term leases of the factory space, providing a lucrative opportunity for investors in the growing generic pharmaceuticals market.

• Established generic pharmaceutical manufacturing unit located in Hyderabad, operational for over 5 years. • Built-up area of 60,000 sq. ft. across 4 floors, each dedicated to specific product lines (tablets, capsules, syrups and powders). • Licensed for manufacturing 300+ medicines and holds GMP certification. • Expansion potential to INR 12–15 crore annually with sufficient working capital infusion. • In-house distribution house established, supported by third-party manufacturing orders. • Current output: 10,000 tablets/day and 500 liters syrup/day with 1 batch/day. • Installed capacity allows up to 3 batches/day for significantly higher production. • Open to outright sale, partial stake (10–80%), or long lease arrangements.

State-of-the-art pharmaceutical R&D facility located in Verna Industrial Estate, South Goa, a prime pharma corridor near ports and airports, and home to top pharma companies like Pfizer, Cipla, Sanofi, Abbott, and Colorcon. In proximity to upcoming dedicated IT Park. - The business can operate on a B2B collaboration model, focusing on R&D execution rather than direct sales of medicine. - Fully equipped, ready-to-operate 3-floor R&D building with dedicated areas for administration, formulation development, and analytical development; upcoming 4-floor pilot manufacturing building beside R&D. - FDA-approved plan from the State of Goa, enabling immediate start of operations with necessary licenses and compliance for both domestic and international markets. - It is a land of 1,800 m² space with 24/7 CCTV, controlled access, a robust electric supply, water purification systems, ETP-certified waste management, and fire safety compliance. The promoter has permission to sublease the property. - Formulation lab fitted with clean rooms, HVAC & AHU systems, HEPA filters, and equipment including high-shear granulators, fluid bed dryers, nano-milling systems, spray drying tech, multi-layer tablet press, and encapsulation machines. - Analytical lab equipped with advanced instruments such as Malvern Mastersizer, UHPLC, FTIR, DSC, dissolution apparatus, and gas chromatography systems; stability chambers for long-term studies. - The administration area includes open workspaces, conference and meeting rooms, reception, and executive cabins for quality, regulatory, and operational teams. - Additional features: 800 KVA transformer, 380 KVA diesel generator (CPCB-II certified), 160 KVA UPS backup, rainwater drainage, ample parking, and logistics-friendly loading bays. - Offered on a turnkey sale asset basis with all machinery and infrastructure included from day 1, ensuring cost-effective setup and rapid operational launch.

Engaged in pharmaceutical manufacturing, supplying tablets and capsules to both domestic and international markets. - Operates from an 18,000 sq. ft. constructed manufacturing facility located in Gujarat. - The facility supports a monthly production of approximately 4 crore tablets/capsules. - Holds a valid drug license and GST registration, Exim license, ensuring regulatory compliance for manufacturing and distribution. - Business model centers on contract manufacturing and long-term partnerships with pharma companies. - Team includes experienced professionals with technical and regulatory expertise in pharma manufacturing and export compliance.

The company is a WHO GMP standard pharmaceutical firm located in Hinganghat, referred to as the center of India, positioning it strategically for robust distribution. - We specialize in manufacturing high-quality generic drugs, focusing specifically on tablet and capsule forms to cater to a wide range of healthcare needs. - With an impressive manufacturing capacity, the company can produce up to 40 lakh tablets per day, ensuring the ability to meet both domestic and international demand efficiently. - As an FDA-approved entity in the countries where they export, the business adheres to stringent quality regulations, enhancing their credibility and reliability on a global scale. - The business predominantly generates revenue through exports, supported by approvals from NAFDAC, Ghana, and Uzbek FDA, indicating strong international market presence. - Operating on a job work model, the company collaborates with over 10 merchant exporters who have registered products, demonstrating robust partnerships in the pharmaceutical export industry. - The promoters bring over 25 years of combined experience, underscoring the business's depth in pharmaceutical industry knowledge and operational prowess. - There are 80 permanent employees, with additional contract or temporary staff hired for manufacturing and logistics based on operational needs and demand.